Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Amanda J Watson

Showing results (21-30 of 30) with videos related to

Pageof 3
Sort By:
You have reached the last page of results.This site can display upto 30 results.
Carcinogenesis|April 16, 2005
Quantitative trait locus analysis reveals two intragenic sites that influence O6-alkylguanine-DNA alkyltransferase activity in peripheral blood mononuclear cellsGeoffrey P Margison, Jim Heighway, Steven Pearson, et al.
Oncotarget|October 27, 2015
IGF-1R inhibition induces schedule-dependent sensitization of human melanoma to temozolomideRoger Ramcharan, Tamara Aleksic, Wilfride Petnga Kamdoum, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 4, 2005
Temozolomide pharmacodynamics in patients with metastatic melanoma: dna damage and activity of repair enzymes O6-alkylguanine alkyltransferase and poly(ADP-ribose) polymerase-1E Ruth Plummer, Mark R Middleton, Christopher Jones, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 20, 2007
Randomized trial of the combination of lomeguatrib and temozolomide compared with temozolomide alone in chemotherapy naive patients with metastatic cutaneous melanomaMalcolm Ranson, Peter Hersey, Damien Thompson, et al.
Bioorganic & Medicinal Chemistry Letters|April 18, 2016
Anilinoquinazoline inhibitors of the RET kinase domain-Elaboration of the 7-positionAllan M Jordan, Habiba Begum, Emma Fairweather, et al.
Molecular Cell|June 5, 2012
Atl1 regulates choice between global genome and transcription-coupled repair of O(6)-alkylguaninesVitaly F Latypov, Julie L Tubbs, Amanda J Watson, et al.
Proceedings of the National Academy of Sciences of the United States of America|November 1, 2012
Alkyltransferase-like protein (Atl1) distinguishes alkylated guanines for DNA repair using cation-π interactionsOliver J Wilkinson, Vitaly Latypov, Julie L Tubbs, et al.
Journal of Medicinal Chemistry|July 18, 2013
Toxoflavins and deazaflavins as the first reported selective small molecule inhibitors of tyrosyl-DNA phosphodiesterase IIAli Raoof, Paul Depledge, Niall M Hamilton, et al.
Nature|June 12, 2009
Flipping of alkylated DNA damage bridges base and nucleotide excision repairJulie L Tubbs, Vitaly Latypov, Sreenivas Kanugula, et al.
European Journal of Medicinal Chemistry|February 15, 2016
The discovery of 2-substituted phenol quinazolines as potent RET kinase inhibitors with improved KDR selectivityRebecca Newton, Katherine A Bowler, Emily M Burns, et al.
Pageof 3

Showing results (21-30 of 30) with videos related to

Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 30 results.
Carcinogenesis|April 16, 2005
Quantitative trait locus analysis reveals two intragenic sites that influence O6-alkylguanine-DNA alkyltransferase activity in peripheral blood mononuclear cellsGeoffrey P Margison, Jim Heighway, Steven Pearson, et al.
Oncotarget|October 27, 2015
IGF-1R inhibition induces schedule-dependent sensitization of human melanoma to temozolomideRoger Ramcharan, Tamara Aleksic, Wilfride Petnga Kamdoum, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 4, 2005
Temozolomide pharmacodynamics in patients with metastatic melanoma: dna damage and activity of repair enzymes O6-alkylguanine alkyltransferase and poly(ADP-ribose) polymerase-1E Ruth Plummer, Mark R Middleton, Christopher Jones, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 20, 2007
Randomized trial of the combination of lomeguatrib and temozolomide compared with temozolomide alone in chemotherapy naive patients with metastatic cutaneous melanomaMalcolm Ranson, Peter Hersey, Damien Thompson, et al.
Bioorganic & Medicinal Chemistry Letters|April 18, 2016
Anilinoquinazoline inhibitors of the RET kinase domain-Elaboration of the 7-positionAllan M Jordan, Habiba Begum, Emma Fairweather, et al.
Molecular Cell|June 5, 2012
Atl1 regulates choice between global genome and transcription-coupled repair of O(6)-alkylguaninesVitaly F Latypov, Julie L Tubbs, Amanda J Watson, et al.
Proceedings of the National Academy of Sciences of the United States of America|November 1, 2012
Alkyltransferase-like protein (Atl1) distinguishes alkylated guanines for DNA repair using cation-π interactionsOliver J Wilkinson, Vitaly Latypov, Julie L Tubbs, et al.
Journal of Medicinal Chemistry|July 18, 2013
Toxoflavins and deazaflavins as the first reported selective small molecule inhibitors of tyrosyl-DNA phosphodiesterase IIAli Raoof, Paul Depledge, Niall M Hamilton, et al.
Nature|June 12, 2009
Flipping of alkylated DNA damage bridges base and nucleotide excision repairJulie L Tubbs, Vitaly Latypov, Sreenivas Kanugula, et al.
European Journal of Medicinal Chemistry|February 15, 2016
The discovery of 2-substituted phenol quinazolines as potent RET kinase inhibitors with improved KDR selectivityRebecca Newton, Katherine A Bowler, Emily M Burns, et al.
Pageof 3